Literature DB >> 12633790

Hip fracture patients have more vertebral deformities than subjects in population-based studies.

R Hasserius1, O Johnell, B E Nilsson, K-G Thorngren, K Jonsson, D Mellström, I Redlund-Johnell, M K Karlsson.   

Abstract

The prevalence of vertebral deformity, estimated in lateral spine radiographs (Th4-L4) using quantitative morphometry, in 64 men and 132 women with hip fractures was compared with the prevalence of vertebral deformity in individuals in two population-based studies. A vertebral deformity of a specific vertebra was defined as a 3, 4, or 5 SD reduction from the normal mean of any of three ratios describing that specific vertebra. The age-adjusted prevalence of individuals with vertebral deformities was higher among the hip fracture patients than among the reference subjects in both genders, with an odds ratio of 3.6 [95% confidence interval (CI) 1.9-6.6] in men and 2.6 (95% CI 1.7-4.1) in women using deformity criterion -3 SD. Also, the number of vertebrae with deformities (-3 SD) in individuals with one deformity or more was greater among the hip fracture patients than among the reference subjects (in men mean 2.3 versus 1.8, P = 0.007; in women mean 3.3 versus 2.0, P < 0.001). Adjusted for age there were more vertebrae with deformities (-3 SD) among female than among male hip fracture patients (mean 3.3 versus 2.3, P = 0.01). We found no differences in the vertebral deformity rates when comparing patients with a per- or subtrochanteric hip fracture with patients with a cervical hip fracture. In conclusion, there is a relationship between vertebral deformities and hip fractures suggesting that a prevalent vertebral deformity could predict an increased hip fracture risk.

Entities:  

Mesh:

Year:  2003        PMID: 12633790     DOI: 10.1016/s8756-3282(02)00951-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Clinical comparison of postoperative results of balloon kyphoplasty (BKP) versus radiofrequency-targeted vertebral augmentation (RF-TVA): a prospective clinical study.

Authors:  A Petersen; E Hartwig; E M W Koch; M Wollny
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-01

2.  Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study.

Authors:  Christina Sjöberg; Lina Bladh; Lars Klintberg; Dan Mellström; Claes Ohlsson; Susanna M Wallerstedt
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

3.  The assessment of vertebral fractures in elderly women with recent hip fractures: the BREAK Study.

Authors:  S Gonnelli; C Caffarelli; S Maggi; S Rossi; P Siviero; G Gandolini; C Cisari; M Rossini; G Iolascon; G Letizia Mauro; G Crepaldi; R Nuti
Journal:  Osteoporos Int       Date:  2012-08-22       Impact factor: 4.507

4.  Severity of vertebral fracture and risk of hip fracture: a nested case-control study.

Authors:  V Puisto; M Heliövaara; O Impivaara; T Jalanko; H Kröger; P Knekt; A Aromaa; H Rissanen; I Helenius
Journal:  Osteoporos Int       Date:  2010-02-27       Impact factor: 4.507

5.  Prevalence of osteoporosis in men aged 65-75 in a primary care setting. A practice audit after application of the Canadian 2010 guidelines for osteoporosis screening.

Authors:  Robert Ferrari
Journal:  Clin Rheumatol       Date:  2014-04-30       Impact factor: 2.980

6.  Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.

Authors:  A Frederiksen; B Abrahamsen; P B Johansen; H A Sørensen
Journal:  Osteoporos Int       Date:  2017-09-30       Impact factor: 4.507

7.  Association of early vertebroplasty with risk of hip replacement: A nationwide population-based cohort study in Taiwan.

Authors:  Chiao-Zhu Li; Chiao-Ching Li; Chi-Tun Tang; Chi-Hsiang Chung; Chien-Yu Ou; Chun-Lin Chen; Nan-Fu Chen; Tzu-Tsao Chung; Dueng-Yuan Hueng; Hsin-I Ma; Ming-Ying Liu; Yuan-Hao Chen; Wu-Chien Chien; Da-Tong Ju
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.